A CONSIDERABLE number of investigations undertaken during recent years have shown that factors which suppress the function of lymphoreticular endothelial cell may be released by or extracted from a variety of tumours. For example, factors have been reported which suppress (a) the in vitro response of spleen cells to mitogens and alloantigens (De Lustro and Argyris, 1976) and sheep erythrocytes (Wong, Mankovitz and Kennedy, 1974; Kamo et al., 1975) ; (b) macrophage chemotaxis in vitro (Meltzer and Stevenson, 1977a, b; Normann and Sorkin, 1977; Snydermann and Pike, 1976; Pike and Snydermann, 1976) and in vivo ; (c) macrophagemediated resistance to infection (North, Kirstein and Tuttle, 1976a, b) ; and (d) the in vivo response to syngeneic (North et al., 1976b; Nelson and Nelson, 1977) and allogeneic (Bonmassar et al., 1973) tumour transplants. It would also appear that the inhibitory effects observed in vivo are not always dependent upon the presence of a large tumour mass, for they may be evident within 24 h of the s.c. transplantation of 106 tumour cells (North et al., 1976a, b) .
The observed effects on macrophage function have led to the suggestion that neoplastic cells may abrogate or interfere with the early phases of immunosurveillance by releasing products which modify the localization and/or activity of macrophages North et at., 1976a, b; Nelson and Nelson, 1977) . In view of the above suggestions and the observations of North et al. (1976a, b) , we thought it was important to establish whether the injection of syngeneic tumour cells shortly before i.v. challenge with the same tumour cells would increase the incidence of artificial metastases, or interfere with the capacity of macrophages to exert a cytostatic effect on syngeneic target cells in vitro. Contrary to expectations we found that the injection of syngeneic tumour cells as late as 1 day K. JAMES, R. T. CULLEN, 1. MILNE AND M. NORVAL before i.v. challenge inhibited the development of artificial metastases. It had, however, a less consistent effect upon the cytostatic activity of peritoneal exudate cells harvested within 2 days of tumour injection. MATERIALS Tumours.-A number of tumours were used in these studies. They include (a) MC fibrosarcomas from a number of strains of mice; (b) a fibrosarcoma which had been obtained by injecting CBA/Ca mice with syngeneic embryo cells which had transformed in vitro; and (c) an adenocarcinoma which had spontaneously appeared in CBA/Ca mice. Further details on the origin, generation number and designation of these tumours are presented in Table I .
Cultured MC-induced CBA fibrosarcoma cells (CCH1) were generally used for pretreatment and always used for challenge. These cells had been maintained for 3-18 months in culture, as previously described (Ghaffar et al., 1974) . The T3 fibrosarcoma cell line was also maintained in culture. All the other tumour-cell suspensions used were obtained by pronase digestion of freshly excised tumour cells (Woodruff and Boak, 1966) .
X-Irradiation.-Tumour cells were irradiated at a dose rate of 274 rad/min to a total of 22,000 rad using a Westinghouse X-ray machine operating at 220 kV and 15 mA, with HVL of 1 2 Cu under conditions of maximum backscatter.
In vivo experimental model. In vitro cytostatic assay.-The procedure used has been described in greater detail elsewhere (Ghaffar et al., 1974) . In essence it involved the addition of test effector cells to tumour-cell monolayers in the wells of plastic microculture plates and incubating the plates at 37°C for 48 b. At this stage, the culture medium (see below) was replaced by fresh medium containing 1251-iododeoxyuridine (Radiochemical Centre, Amersham, England). The incorporation of this thymidine analogue into the tumour-cell monolayer was assessed 20 h later in an LKB WVallac gamma scintillometer. The spleen cells whose cytostatic activity was being assessed wvere obtained by gentle disruption in cold medium in a hand-operated glass homogenizer while the peritoneal exudate cells w%ere obtained by washing out the peritoneal cavity with 3 ml of medium containing 10 u of heparin/ml. These cells were alw%Aays washed x 3 before use. Throughout these in vitro studies, the medium used was RPMI 1640 (Gibco Biocult, Paisley, Scotland) buffered with 20 mm HEPES and supplemented with 10% (vol/ vol) foetal calf serum, 100 u/ml penicillin and 100 ,ug/ml streptomycin.
Bacteriological and virological investigations.-A variety of standard procedures were used to ascertain if the cultured CBA MC fibrosarcoma cell line routinely used in these studies (that is, CCH1) was contaminated with micro-organisms which might influence antitumour responses. In brief these included electronmicroscopic examination of tumour cell sections, the screening of cells and culture supernatants for mycoplasma (McKay et al., 1974) , reverse transcriptase assays using the method of Dr Natalie Teich (personal communication) and indirect immunofluorescence on acetone-fixed cells (Hart and Marmion, 1977) (Woodruff and Dunbar, 1973) .
§ In all 28 experiments the growth of tumour was inhibited, but this inhibition failed to reach significant levels in 8 experiments. On all these occasions a suspension of freshly excised tumour cells had been injected. ence of s.c. growing tumour reduced the number of artificial pulmonary metastases which could be induced by the i.v. injection of syngeneic tumour cells (Milas et at., 1974) . These workers also demonstrated by adoptive transfer that the resistance conferred was immunologically mediated, protection being most effectively transferred by cells from mice challenged 12 days previously with viable tumour cells. We decided therefore to investigate in more detail the development of artificial pulmonary metastases in mice which had been injected s.c. with syngeneic tumour cells at various times before and after i.v. challenge.
The initial "short-term" pretreatment experiment involved injecting mice s.c. with 106 viable syngeneic tumour cells on either Day -3, -2, -1, 0 or +1 in relation to i.v. challenge with 5 x 104 tumour cells, and 2 weeks after challenge the number of lung metastases formed was assessed. Significant suppression of metastasis was observed in all mice pretreated with syngeneic tumour cells, but was not achieved in mice treated after i.v. challenge (Fig. 5) , thus confirming our preliminary observation (Fig. 3) .
A further experiment was performed in which mice were injected s.c. with 106 viable syngeneic tumour cells 14, 7 and 2 days before i.v. challenge. A significant reduction in pulmonary metastasis was noted following pretreatment at all these times.
The specificity of the protection conferred was assessed by pretreating the CBA mice with a variety of tumours of syngeneic and allogeneic origin. The results of one such experiment are shown in Fig. 7 . It will be observed that pretreat- Non-adherentt PEC 15,534 (14,699-16,416) 27,901 (27, 670) 14,701 (13,514-15,991) 28,291 (27,977-28,609) 36,435 (33,945-39,109) * Peritoneal exudate cells. Note: The marked reduction in the cytostatic effect of PEC on CCH1 tumour monolayers after removal of glass-adherent cells. This was apparent with PEC from both saline controls and tumour-pretreated mice. spleen cells etc. on monolayers of the same tumour was assessed. In the majority of experiments, this short-term pretreatment produced a significant increase in the cytostatic activity of peritoneal exudate cells. Results from a typical experiment are presented in Table II . It was generally found that PEC from control mice express a cytostatic effect at the higher effector-totarget ratios and that preinjection with tumour increases this effect. It will also be observed that lethally irradiated tumour cells were also capable of stimulating the cytostatic activity of PEC. To date, no effect on the antitumour activity of cells from peripheral blood, spleen and lymphnode cells has been observed using this short-term tumour pretreatment (data not shown).
The cytostatic component of both normal PEC and tumour-stimulated PEC appeared to be associated with a glassadherent population (Table III) . This would suggest that the effects are mediated by macrophages but this will require confirmation by further analysis.
Further studies revealed that the increased cytostatic activity of PEC after injection with syngeneic tumour (CCH1) could also be achieved using an allogeneic MC fibrosarcoma of C3H origin (Expt. 1, Table IV ). It was not observed, however, following pretreatment with a spontaneous syngeneic tumour (W54). On the contrary, treatment with the spontaneous tumour resulted in a marked decrease in cytostasis.
Abrogation or reduction of cytostasis has also been observed in a minority of experiments with the syngeneic and allogeneic MC fibrosarcomas (Expt. 2, Table  IV ) and appears to be associated with an extremely high cytostatic activity in the PEC of control mice. Such high levels of activity may be due to transient infection in the mouse colony, leading to stimulation of the lymphoreticular system as described by Hibbs, Lambert and Remington (1972) and Krahenbuhl and Remington (1974) .
Finally, it should perhaps be noted that the marked cytotoxicity normally elicited in PEC after i. The present observations are similar in certain respects to those noted in less extensive studies from other laboratories (Milas et al., 1974;  Yuhas, Pazmino and Wagner, 1975;  McBride, personal communication). They differ, however, from those recently reported by other investigators in other models (North et al., 1976; Nelson and Nelson, 1977) and are difficult to reconcile with previous suggestions that the initial survival of tumours may be due to their ability to suppress macrophage-mediated surveillance mechanisms (North et al., 1976a, l; Nelson and Nelson, 1977; Snyderman and Pike, 1976) .
At the present time, the mechanism whereby the preinjection of tumour-cells can inhibit the growth of the same tumour injected i.v. only one or 2 days later remains to be established. However, observations in other tumour systems suggest a number of ways in which this rapid effect might be achieved. In the first place, the injection of various tumours has been found to result in the appearance within one day of suppressor T cells (Fujimoto, Greene and Sehon, 1976) , whilst cytotoxic cell activity was apparent within 3 days of challenge (Schick and Berke, 1976) . Others have also shown that the injection of tumours or tumour-cell extracts in rats induces within 2 days mitosis in sinus macrophages in the draining lymph nodes and a peripheral blood monocytosis (Carr, Price and Westby, 1976) . Additional studies had revealed that the ability of tumour to produce monocytosis appears to be directly related to its antigenicity (Eccles, Bandlow and Alexander, 1976) . Thus, in theory at least, the effect might be due to a rapidly induced increase in T-cell cytoxicity or macrophage activity. Alternatively, if the initial growth of tumours is dependent upon immunostimulation (see Prehn, 1976 ) it might be due to the rapid development of suppressor T cells. In addition, the possibility of a prompt effect of natural killer (NK) cell activity cannot be excluded.
The Our extensive bacteriological and virological investigations, together with the fact that the effect can be achieved with UV-irradiated cells, leads us to conclude that our observations are probably not due to contamination with microorganisms such as the LDH virus which is known to be present in many tumours (Riley, 1968) and has been found to modulate the immune response of the tumour-bearing host (Kamo, Patel and Friedman, 1976) . In any case it is known that the LDH virus, which replicates in macrophages (Kamo et al., 1976) , does not usually survive for more than 10 days in culture. Indeed this property is exploited to remove the virus from infected tumours (Riley, 1968) . Nevertheless, the possibility still remains that the effect is due to contamination with some as yet undetected virus such as the minute virus of mice which has recently been shown to be responsible for the immunosuppressive effects of mouse EL-4 lymphoma cells on the mixed lymphocyte reaction (Bonnard et al., 1976) .
The present results are of particular interest in view of the recent flourish of reports indicating that tumours and tumour-cell products may interfere with the development and activity of cells of the monocyte macrophage series (see introduction and James, 1977) . These observations have led to the suggestion that tumours may initially become established by suppressing macrophage-mediated surveillance mechanisms (North et al., 1976a, b; Snyderman and Pike, 1976; Nelson and Nelson, 1977) . The present observations, however, emphasize that the picture is far more complicated than suggested above, for pretreatment with tumour may on occasions inhibit rather than promote the growth of tumour injected shortly afterwards. In addition there is also a number of reports indicating that tumours may actually stimulate macrophage development and activity, these effects being noted within 2-3 days of tumour challenge (James, 1977) . It is obvious that the effects of tumour on macrophage function are complex and diverse. Indeed it has recently been shown that short-term pretreatment with tumour may inhibit the chemotactic responses of peritoneal macrophages whilst simultaneously enhancing their capacity to phagocytose antibodycoated shieep erythrocytes (Meltzer and Stevenson, 1977a) . Furthermore, it is apparent from the present studies that pretreatment with allogeneic tumour may enhance the cytostatic effect of peritoneal exudate cells without suppressing the development of tumour metastases. It is apparent, therefore, that further studies will be necessary to (a) explain these divergent effects; (b) elucidate their cellular and molecular basis; (c) establish their relative importance with respect to the initial phases of tumour growth; and (d) to identify and characterize the tumour products which modulate the host response to tumours. Finally it must be emphasized that such studies should be performed with tumours which are free (as far as can be reasonably ascertained) from contamination with viruses and other micro-organisms which are known to influence the function of cells of the lymphoreticular system.
